Walgreen, Par Accused of Plot to Overcharge for Generic Drugs

Walgreen Co., the biggest U.S. drugstore chain, and generic drugmaker Par Pharmaceutical Cos. were accused in a lawsuit of swapping prescription-drug tablets for more expensive capsules to boost profits.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.